Join our mailing list to receive the latest updates and alerts Flag Subscribe

Fredrikson & Byron acted as legal counsel for Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, a company engaged in the development, manufacture and sale of biotechnology products and clinical calibrators and controls, in its $10 million equity investment in CyVek, Inc. (CyVek), which Bio-Techne has agreed to acquire if certain future milestones are met. CyVek is a privately funded biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The investment closed on April 4, 2014. Fredrikson’s legal team included Alexander Rosenstein, Andrew M. Nick, Amanda L. Welters and Lori P. Cobb.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.